THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 111 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $449 | -16.7% | 52 | 0.0% | 0.00% | – |
| Q2 2023 | $539 | -4.6% | 52 | 0.0% | 0.00% | – |
| Q1 2023 | $565 | -60.7% | 52 | -59.4% | 0.00% | – |
| Q4 2022 | $1,436 | +43.6% | 128 | -5.2% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 135 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 135 | -22.4% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 174 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | – | 174 | +370.3% | 0.00% | – |
| Q3 2021 | $0 | – | 37 | +48.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 25 | -98.5% | 0.00% | -100.0% |
| Q1 2020 | $39,000 | -9.3% | 1,693 | +0.5% | 0.01% | +40.0% |
| Q4 2019 | $43,000 | +34.4% | 1,685 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $32,000 | – | 1,685 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |